MCP Agilent Technologies
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Glossary
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kenyon, G. L.
Right arrow Articles by Sheahan, L. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kenyon, G. L.
Right arrow Articles by Sheahan, L. C.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Molecular & Cellular Proteomics 1:763-780, 2002.
© 2002 by The American Society for Biochemistry and Molecular Biology, Inc.


Report

Defining the Mandate of Proteomics in the Post-Genomics Era: Workshop Report

©2002 National Academy of Sciences, Washington, D.C., USA. Reprinted with permission from the National Academies Press for the National Academy of Sciences. All rights reserved. The original report may be viewed online at http://www.nap.edu/catalog/10209.html

National Research Council Steering Committee: George L. Kenyon, (Chair)*,a, David M. DeMarinib, Elaine Fuchsc, David J. Galasd, Jack F. Kirsche, Thomas S. Leyh, (Contributing Author)f, Walter H. Moosg, Gregory A. Petskoh, Dagmar Ringei, Gerald M. Rubinj and Laura C. Sheahan, (Staff Director)k

a College of Pharmacy, University of Michigan, Ann Arbor, MI 48109-1065
b U.S. Environmental Protection Agency, Research Triangle Park, NC 27711
c The Rockefeller University, New York, NY 10021
d Keck Graduate Institute of Applied Life Sciences, Claremont, CA 91711
e Department of Molecular and Cellular Biology, University of California-Berkeley, Berkeley, CA 94720-3206
f Department of Biochemistry, Albert Einstein College of Medicine, Bronx, NY 10461-1975
g MitoKor, San Diego, CA 92121
h Department of Chemistry and Biochemistry, Rosenstiel Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02254-9110
i W.M. Keck Institute for Cellular Visualization, Rosensteil Basic Medical Sciences Research Center, Brandeis University, Waltham, MA 02254-9110
j Howard Hughes Medical Institute, Chevy Chase, MD 20815-6789
k Program Officer, Board on International Scientific Organizations, Policy and Global Affairs, The National Academies, Washington, D.C. 20418

Research in proteomics is the next step after genomics in understanding life processes at the molecular level. In the largest sense proteomics encompasses knowledge of the structure, function and expression of all proteins in the biochemical or biological contexts of all organisms. Since that is an impossible goal to achieve, at least in our lifetimes, it is appropriate to set more realistic, achievable goals for the field. Up to now, primarily for reasons of feasibility, scientists have tended to concentrate on accumulating information about the nature of proteins and their absolute and relative levels of expression in cells (the primary tools for this have been 2D gel electrophoresis and mass spectrometry). Although these data have been useful and will continue to be so, the information inherent in the broader definition of proteomics must also be obtained if the true promise of the growing field is to be realized. Acquiring this knowledge is the challenge for researchers in proteomics and the means to support these endeavors need to be provided. An attempt has been made to present the major issues confronting the field of proteomics and two clear messages come through in this report. The first is that the mandate of proteomics is and should be much broader than is frequently recognized. The second is that proteomics is much more complicated than sequencing genomes. This will require new technologies but it is highly likely that many of these will be developed. Looking back 10 to 20 years from now, the question is: Will we have done the job wisely or wastefully? This report summarizes the presentations made at a symposium at the National Academy of Sciences on February 25, 2002.


* To whom correspondence should be addressed: College of Pharmacy, University of Michigan, 428 Church Street, Ann Arbor, MI 48109-1065. Tel.: 734-764-7144; E-mail: gkenyon{at}umich.edu


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Nucleic Acids ResHome page
W. Tian, A. K. Arakaki, and J. Skolnick
EFICAz: a comprehensive approach for accurate genome-scale enzyme function inference
Nucleic Acids Res., December 1, 2004; 32(21): 6226 - 6239.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Journal of Biological Chemistry 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.